Skip to content

Nuvalent, Inc. NUVL Operating Cash Flow

Operating Cash Flow at other companies

Pfizer logo
PfizerPFE
$2.62B+12.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$75.36M+12.3%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$122.29M-99.9%
Exelixis logo
ExelixisEXEL
$251.85M+19.1%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$354.17M-82.2%
Incyte logo
IncyteINCY
$369.35M+38.8%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s operating cash flow?
Nuvalent, Inc. (NUVL) reported operating cash flow of -$92.4M in Q1 2026.
How has Nuvalent, Inc.'s operating cash flow changed year-over-year?
Nuvalent, Inc.'s operating cash flow decreased by 68.5% year-over-year, from -$54.82M to -$92.4M.
What is the long-term trend for Nuvalent, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s operating cash flow has grown at a 62.0% compound annual growth rate (CAGR), from -$40M to -$275.21M.
What does operating cash flow mean?
The actual cash generated or spent by the core business.
How do you interpret operating cash flow?
Positive cash flow indicates a self-sustaining business, while negative cash flow signals a reliance on external capital.
How does operating cash flow compare across companies?
Essential for comparing the operational health of companies within the same industry.